APEX1 and non-small cell lung carcinoma: Up-regulated or activated APE1 has been identified in several tumors, such as non-small cell lung cancer (NSCLC), gastric cancer, esophageal squamous cell carcinoma (ESCC) and bladder cancers [5–8], and is associated with a worse prognosis.